New imaging-guided radiation aims to halt kidney cancer spread
NCT ID NCT07540260
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether combining a special PET scan (CAIX PET/CT) with standard therapy can better control advanced kidney cancer. About 70 adults with recurrent or metastatic clear cell renal cell carcinoma will receive targeted therapy and immunotherapy, plus precise radiation to visible tumors. The goal is to delay cancer progression and improve local control of treated lesions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLEAR CELL RENAL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking University First Hospital
RECRUITINGBeijing, Beijing Municipality, 100034, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a PET scan reveal hidden heart harm from lung cancer treatment?
- Could a chemo boost after radiation tame aggressive prostate cancer?
- Can a Two-Pronged immune attack shrink kidney tumors before surgery?
- Can a tracer that hunts unstable iron light up hidden tumors?
- Can a pill that starves tumors of oxygen help fight advanced cancer?
- Drug cocktail aims to shrink kidney tumors before surgery and prevent return